Photo: BING-JHEN HONG (Getty Images) The escalating chip war between the U.S. and China, compounded by a series of retaliatory tariffs, is poised to have far-reaching consequences for the global AI industry. Major AI stocks in the U.S., including Nvidia (NVDA), Super Micro Computer (SMCI), and Advanced Micro Devices (AMD), continued to climb Wednesday. However,…
Good morning! Meta’s elimination of fact-checking opens the door to misogynistic speech, Jane Fraser faces a test at Citi, and Fortune’s Alexa Mikhail reports on Thrive Global’s innovative partnership in the health care space. – Healthy habits. Arianna Huffington’s Thrive Global aims to help people build healthy habits. Today, the company announced a partnership with…
US Secretary of Health and Human Services nominee Robert F. Kennedy Jr. departs the New York Stock Exchange (NYSE) on December 12, 2024 in New York City. US President-elect Donald Trump rang the opening bell at the New York Stock Exchange on Thursday morning.Image: David Dee Delgado / Contributor (Getty Images) In This Story Robert…
Executives of those companies scoff at all this. Many say they now struggle to justify investing in the country and talk instead of cutting staff. In a recent survey by the American Chamber of Commerce in Shanghai, less than half of respondents said they were optimistic about the prospects for their business in China over…
The recent volatility in key GLP-1 stocks has put the spotlight on the anxiety Wall Street has about the weight loss market. The market is huge — a potential $150 billion a year by the end of the decade — and any financial miss, or negative data of any kind, will trigger outsized sell-offs. This…
The latest celebrity weight-loss drug to be given the nod in Hong Kong will be available in December, but experts cautioned against using it for cosmetic purposes without a doctor’s prescription. US drug giant Eli Lilly announced last month that Mounjaro, for treating obesity and type 2 diabetes, had been approved by the Department of…
The latest celebrity weight-loss drug to be given the nod in Hong Kong will be available in December, but experts cautioned against using it for cosmetic purposes without a doctor’s prescription. US drug giant Eli Lilly announced last month that Mounjaro, for treating obesity and type 2 diabetes, had been approved by the Department of…
Google reported strong earnings after the close Tuesday. (Photo by Alexander Koerner/Getty Images) Getty Images Key Takeaways Tech Earnings And Economic Data Bring Mixed Signals For Market Direction Alphabet’s Strong Cloud Growth Boosts Sector; AMD Dips On Guidance Optimism Grows Despite Mixed Earnings And Slight Economic Slowdown Signs It’s been a quiet start to the…
In This Story This week promises to be exceptionally busy, with a blend of financial updates and festive celebrations. Investors are bracing for a flurry of major earnings reports, providing a crucial snapshot of how various sectors are navigating the current economic landscape. McDonald’s is facing its first lawsuit from the Quarter Pounder E. coli…
The UK government has announced a novel initiative trial to offer weight loss medication Mounjaro to people with obesity who are unemployed, to improve their health and help them re-enter the workforce, said British Health Minister Wes Streeting said on Tuesday. The trial is part of a broader NHS strategy that offers weight-loss medication to…